WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012089051) BENZOPYRONE ESTROGEN RECEPTOR REGULATOR
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/089051    International Application No.:    PCT/CN2011/084321
Publication Date: 05.07.2012 International Filing Date: 21.12.2011
IPC:
C07D 311/30 (2006.01), C07D 311/54 (2006.01), C07D 311/60 (2006.01), C07D 311/76 (2006.01), A61K 31/352 (2006.01), A61P 35/00 (2006.01), A61P 35/02 (2006.01), A61P 35/04 (2006.01)
Applicants: BEIJING SHENOGEN PHARMA GROUP LTD. [CN/CN]; Suite A205 No. 5 Shangdi Kaituo Road Haidian, Beijing 100085 (CN) (For All Designated States Except US).
DING, Hongxia [CN/CN]; (CN) (For US Only).
MENG, Kun [CN/CN]; (CN) (For US Only).
LI, Jin [US/CN]; (CN) (For US Only)
Inventors: DING, Hongxia; (CN).
MENG, Kun; (CN).
LI, Jin; (CN)
Agent: LIU, SHEN & ASSOCIATES; A0601, Huibin Building No. 8 Beichen Dong Street Chaoyang District, Beijing 100101 (CN)
Priority Data:
201010617285.5 31.12.2010 CN
201110378158.9 24.11.2011 CN
Title (EN) BENZOPYRONE ESTROGEN RECEPTOR REGULATOR
(FR) RÉGULATEURS DE RÉCEPTEURS DES ŒSTROGÈNES À BASE DE BENZOPYRONE
(ZH) 苯并吡喃酮类雌激素受体调节剂
Abstract: front page image
(EN)The present invention provides a kind of benzopyrone compounds having a structure of formula (I) and the pharmaceutically acceptable salts or prodrugs thereof, and the pharmaceutical compositions containing such compounds, which can be used to regulate the novel estrogen receptor ER-α36, and prevent and/or treat the related diseases mediated by the ER-α36 receptor, such as cancers, etc.
(FR)La présente invention concerne une sorte de composés de benzopyrone ayant une structure de formule (I) ainsi que leurs sels ou promédicaments pharmaceutiquement acceptables, et les compositions pharmaceutiques contenant lesdits composés, qui peuvent être utilisées pour réguler le nouveau récepteur des œstrogènes ER-a36, et prévenir et/ou traiter les maladies associées médiées par le récepteur ER-a36, comme les cancers, etc.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)